Home > Insider Trading > Filing (0001209191-23-029521)

Filing Details

Accession Number:: 0001209191-23-029521
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-15 17:06:16
Reporting Period:: 2023-05-11

Accepted Time:: 2023-05-15 17:06:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1693011	Inozyme Pharma Inc.	INZY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1551966	Lorne Robert Hopfner	C/O Inozyme Pharma, Inc. 321 Summer Street Suite 400 Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-11	219,230	$6.48	3,432,816	No	4	P	Indirect	By Pivotal
Common Stock	Acquisiton	2023-05-12	228,702	$6.25	3,661,518	No	4	P	Indirect	By Pivotal

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Pivotal
No	4	P	Indirect	By Pivotal

Footnotes

2,771,391 of the reported shares are held directly by Pivotal bioVenture Partners Fund I, L.P and 661,425 of the reported shares are held by Pivotal bioVenture Partners Fund II, L.P. (collectively, "Pivotal").
The general partner of Pivotal is Pivotal bioVenture Partners Fund I G.P., L.P. ("Pivotal GP"). The general partner of Pivotal GP is Pivotal bioVenture Partners Fund I U.G.P., Ltd (the "Ultimate General Partner").
Pivotal Partners is wholly owned by Pivotal Life Sciences Holdings Limited ("Pivotal Life Sciences"). Pivotal Life Sciences is wholly owned by Nan Fung Life Sciences Holdings Limited ("Nan Fung Life Sciences"), and Nan Fung Life Sciences is wholly owned by NF Investment Holdings LImited ("NFIHL"), which is wholly owned by Nan Fung Group Holdings Limited ("NFGHL"). The members of the Executive Committee of NFGHL make investment decisions with respect to the securities of the Issuer held by Pivotal. Mr. Kam Chung Leung, Mr. Frank Kai Shui Seto, Mr. Vincent Sai Sing Cheung, Mr. Pui Kuen Cheung, Ms. Vanessa Tih Lin Cheung, Mr. Meng Gao and Mr. Chun Wai Nelson Tang are the members of the Executive Committee of NFGHL. Robert Hopfner, a managing partner of the Ultimate General Partner, is a member of the board of directors of the Issuer. Such persons and entities disclaim beneficial ownership over such securities except to the extent of any pecuniary interest therein.
2,804,062 of the reported shares are held directly by Pivotal bioVenture Partners Fund I, L.P and 857,456 of the reported shares are held by Pivotal bioVenture Partners Fund II, L.P.